Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer

Thyroid

Volumn 19, Issue 12, 2009, Pages 1343-1349

  Vriens, Menno R ^a   Suh, Insoo ^a   Moses, Willieford ^a   Kebebew, Electron ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SUSCEPTIBILITY; CARNEY COMPLEX; CHROMOSOME 1Q; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME 8Q; CLINICAL FEATURE; COWDEN SYNDROME; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; FAMILIAL CANCER; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; HISTOLOGY; HUMAN; KIDNEY TUMOR; LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CANCER; THYROID GLAND; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; WERNER SYNDROME;

ADENOMATOUS POLYPOSIS COLI; CARCINOMA, PAPILLARY; CARNEY COMPLEX; GARDNER SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; THYROID NEOPLASMS; WERNER SYNDROME;

EID: 75449101767     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.1607     Document Type: Review

References (60)

1. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
2. Leenhardt L, Grosclaude P, Cherie-Challine L 2004 Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056-1060.
3. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 2004 A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer 83:2638-2648.
4. Baloch ZW, LiVolsi VA 2006 Microcarcinoma of the thyroid. Adv Anat Pathol 13:69-75.
5. Baloch ZW, LiVolsi VA 2005 Pathologic diagnosis of papillary thyroid carcinoma: today and tomorrow. Expert Rev Mol Diagn 5:573-584.
6. Kebebew E 2008 Hereditary non-medullary thyroid cancer. World J Surg 32:678-682.
7. Nosé V 2008 Familial non-medullary thyroid carcinoma: an update. Endocr Pathol 19:226-240.
8. Mears L, Diaz-Cano SJ 2003 Difference between familial and sporadic medullary thyroid carcinomas. Am J Surg Pathol 27:266-267.
9. Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells SA Jr. 2005 Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 353:1105-1113.
10. Wolfe HJ, DeLellis RA 1981 Familial medullary thyroid carcinoma and C cell hyperplasia. Clin Endocrinol Metab 10:351-365.
11. Perry A, Molberg K, Albores-Saavedra J 1996 Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities. Cancer 77:750-756.
12. LiVolsi VA 1997 C cell hyperplasia=neoplasia. J Clin Endocrinol Metab 82:39-41.
13. Ruben Harach H 2001 Familial non-medullary thyroid neoplasia. Endocr Pathol 12:97-112.
14. Eng C 2000 Familial papillary thyroid cancer-many syndromes, too many genes? J Clin Endocrinol Metab 85:1755-1757.
15. Van der Harst E, de Krijger RR, Bruining HA, Lamberts SW, Bonjer HJ, Dinjes WN, Proye C, Koper JW, Bosman FT, Roth J, Heitz PU, Komminoth P 1998 Prognostic value of RET protooncogene point mutations in malignant and benign, sporadic phaeochromocytomas. Int J Cancer 79:537-540.
16. Clark OH 2002 Familial non medullary thyroid cancer. Eur Surg 34:292-295.
17. Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesh P, Raue F, Conte-Devolx B, Drall H 2003 Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517-1525.
18. Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells SA 2005 Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 353:1105-1113.
19. Alsanea O, Clark OH 2001 Familial thyroid cancer. Curr Opin Oncol 13:44-51.
20. Charkes ND 2006 On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 16:181-186.
21. Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH 1995 Familial non-medullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 130:892-897; discussion 8-9.
22. Loh KC 1997 Familial non-medullary thyroid carcinoma: a meta-review of case series. Thyroid 7:107-113.
23. Capezzone M, Marchisotta S, Cantara S, Busonero G, Brilli L, Pazaitou-Panayiotou K, Carli AF, Caruso G, Toti P, Capitani S, Pammolli A, Pacini F 2008 Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15:1075-1081.
24. Alsanea O, Wada N, Ain K, Wong M, Taylor K, Ituarte PH, Treseler PA, Weier HU, Freimer N, Siperstein AE, Duh QY, Takami H, Clark OH 2000 Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128:1043-1050; discussion 50-51.
25. Sippel RS, Caron NR, Clark OH 2007 An evidence-based approach to familial non-medullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924-933.
26. Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Yamashita H, Shuto S 2002 Familial non-medullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26:897-902.
27. Pal T, Vogl FD, Chappuis PO, Tsang R, Brierley J, Renard H, Sanders K, Kantemiroff T, Bagha S, Goldgar DE, Narod SA, Foulkes WD 2001 Increased risk for non-medullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86:5307-5312.
28. Hemminki K, Dong C 2000 Familial relationships in thyroid cancer by histopathological type. Int J Cancer 85: 201-205.
29. Ron E, Kleinerman RA, LiVolsi VA, Fraumeni JF Jr. 1991 Familial non-medullary thyroid cancer. Oncology 48:309-311.
30. Cetta F, Chiappetta G, Melillo RM, Petracci M, Montalto G, Santoro M, Fusco A 1998 The ret=ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. J Clin Endocrinol Metab 83:1003-1006.
31. Cetta F, Montalto G, Gori M, Curia MC, Cama A, Olschwang S 2000 Germline mutations of The APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85:286-292.
32. Cetta F, Pelizzo MR, Curia MC, Barbarisi A 1999 Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. Am J Pathol 155:7-9.
33. Bell B, Mazzaferri EL 1993 Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature. Dig Dis Sci 38:185-190.
34. Camiel MR, Mule JE, Alexander LL, Benninghoff DL 1968 Association of thyroid carcinoma with Gardner's syndrome in siblings. N Engl J Med 278:1056-1058.
35. Haggitt RC, Reid BJ 1986 Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 10:871-887.
36. Mallory SB 1995 Cowden syndrome (multiple hamartoma syndrome). Dermatol Clin 13:27-31.
37. Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, Shawker T 1997 Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 82:2037-2043. (Pubitemid 27287558)
38. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD 1996 Positional cloning of the Werner's syndrome gene. Science 272:258-262.
39. Lupoli Lupoli G, Vitale G, Caraglia M, Fittipaldi MR, Abbruzzese A, Tagliaferri P, Bianco AR 1999 Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 20:637-639.
40. Vriens MR, Sabanci U, Epstein HD, Ngai S, Duh QY, Siperstein AE, Clark OH 1999 Reliability of fine-needle aspiration in patients with familial non-medullary thyroid cancer. Thyroid 9:1011-1016.
41. Triponez F, Wong M, Sturgeon C, Caron N, Ginzinger DG, Segal MR, Kebebew E, Duh QY, Clark OH 2006 Does familial non-medullary thyroid cancer adversely affect survival? World J Surg 30:787-793.
42. Sturgeon C, Clark OH 2005 Familial non-medullary thyroid cancer. Thyroid 15:588-593.
43. Malchoff CD, Sarfarazi M, Tendler B, Forouhar F, Whalen G, Joshi V, Arnold A, Malchoff DM 2000 Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85:1758-1764.
44. Kouvaraki MA, Shapiro SE, Perrier ND, Cote GJ, Gagel RF, Hoff AO, Sherman SI, Lee JE, Evans DB 2005 RET protooncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 15:531-544.
45. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D 1998 A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743-1748.
46. McKay JD, Thompson D, Lesueur F, Stankov K, Pastore A, Watfah C, Strolz S, Riccabona G, Moncayo R, Romeo G, Goldgar DE 2004 Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. J Med Genet 41:407-412.
47. Bonora E, Evangelisti C, Bonichon F, Tallini G, Romeo G 2006 Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas. Br J Cancer 4:1529-1536.
48. Cavaco BM, Batista PF, Martins C, Banito A, do Rosário F, Limbert E, Sobrinho, G, Leite V 2008 Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC=PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 15:207-215.
49. Prazeres HJ, Rodrigues F, Soares P, Naidenov P, Figueiredo P, Campos B, Lacerda M, Martins TC 2008 Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam Cancer 7:141-149.
50. Foukakis T, Thoppe SR, Lagercrantz S, Dwight T, Weng WH, Svensson A, Höög A, Zedenius J, Wallin G, Lui WO, Larsson C 2005 Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors. Int J Oncol 26:141-149.
51. Brunaud L, Zarnegar R, Wada N, Magrane G, Wong M, Duh QY, Davis O, Clark OH 2003 Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial non-medullary thyroid cancer. Thyroid 13:621-629.
52. Hou P, Xing M 2006 Absence of germline mutations in genes within the MAP kinase pathway in familial non-medullary thyroid cancer. Cell Cycle 5:2036-2039.
53. Cavaco BM, Batista PF, Sobrinho LG, Leite V 2008 Mapping a new familial thyroid epithelial neoplasia Susceptibility locus to chromosome 8p23.1-p22 by high-density single nucleotide polymorphism genome-wide linkage analysis. J Clin Endocrinol Metab 93:4426-4430.
54. He H, Nagy R, Liyanarachchi S, Jiao H, Li W, Suster S, Kere J, de la Chapelle A 2009 A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69:625-631.
55. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464.
56. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A 2008 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105:7269-7274.
57. Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, de la Chapelle A 2009 Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA 106:1502-1505.
58. Fontaine JF, Mirebeau-Prunier D, Franc B, Triau S, Rodien P, Houlgatte R, Malthièry Y, Savagner F 2008 Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy. Oncogene 27:2228-2236.
59. Giusti L, Iacconi P, Ciregia F, Giannaccini G, Donatini GL, Basolo F, Miccoli P, Pinchera A, Lucacchini A 2008 Fineneedle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J Proteome Res 7:4079-4088.
60. Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ 2006 Proteomic identification of new biomarkers and application in thyroid cytology. Acta Cytol 50:518-528